Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 38.76-7.1420.1417.5458.34

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is 38.76 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202438.76
Mar2023-7.14
Mar202220.14
Mar202117.54
Mar202058.34

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 38.76
Positive
Mar2023 -7.14
Negative
Mar2022 20.14
14.82
Mar2021 17.54
-69.93
Mar2020 58.34 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,157.8 Cr -1.4% -7.7% 5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.4%

-7.7%

5%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses